And because iniquity shall abound, the love of many shall wax cold.
Matthew 24:12
"Hypocrisy is a terrible trait for anyone to have. When mixed with social
justice causes, it screams out for intervention, but not in 
today’s
upside-down progressive cities.
The Minnesota Department of Health (MDH) is directing hospitals to
blatantly discriminate against white individuals when prioritizing which
patients receive monoclonal antibodies. They have decided to give extra
points for those who are Black, Indigenous, People of Color. The more points you have, the higher on the priority list you go.
Monoclonal
antibodies are made in a laboratory and mimic natural antibodies a
person’s body makes to fight diseases. They’ve been used to treat active
COVID-19 cases and as a preventative for healthy individuals.
With
the increase in popularity of monoclonal antibodies in treating
COVID-19, the extra demand has caused supply to run low across the
country. Some patients have been turned away when attempting to access
monoclonal antibodies.
An MDH document titled “Ethical Framework for Allocation of Monoclonal Antibodies during the COVID-19 Pandemic”
states that “race and ethnicity alone, apart from other underlying
health conditions, may be considered in determining eligibility for mAbs
[monoclonal antibodies].”
Here are the factors and their associated values:
- Being BIPOC (Black, Indigenous, People of Color) (2 points)
- Age 65+ (2 points)
- BMI 35 kg/m2 and higher (2 points)
- Diabetes mellitus (2 points)
- Chronic kidney disease (3 points)
- Heart disease in patients ages 55+ (2 points)
- Chronic respiratory disease in patients ages 55+ (3 points)
- Hypertension in patients age 55+ (1 point)
- Immunocompromised (3 points)
- Pregnancy (4 points)
In
the end, if all factors are the same, the hospitals are required to
give the BIPOC people the treatment first, if some monoclonal antibodies
inventory is remaining then the white patients can get treatment too." PJM